{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fthe-immuno-oncology-podcast.simplecast.com%2Fepisodes%2Fadjuvant-io-therapy-in-uc-uuoDYD3r","width":444,"version":"1.0","type":"rich","title":"Dr. Shilpa Gupta, MD, on an Adjuvant I-O Therapy in UC","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/b0202d52-61d7-4d34-b01e-f88dbffe05ec/3fd74473-fde4-4b84-a1e1-43c0803bc444/podcast-art.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/09389a26-8d90-4f01-98d8-53b5bf9ed81b\" height=\"200\" width=\"100%\" title=\"Dr. Shilpa Gupta, MD, on an Adjuvant I-O Therapy in UC\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Special guest Shilpa Gupta, MD joins us to discuss the various ways to individually approach the adjuvant treatment setting for your patients with radically resected urothelial carcinoma along with their multidisciplinary care team. Dr. Gupta is a genitourinary oncologist at the Cleveland Clinic. Dr Gupta is a paid consultant of BMS.\n\nThis podcast was sponsored by Bristol-Myers Squibb Company."}